Evercore ISI Group Maintains Outperform on Medline, Raises Price Target to $44
Benzinga Newsdesk 42 minutes ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform and raises the price target from $38 to $44.
Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform and raises the price target from $38 to $44.